SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-370585
Filing Date
2021-12-30
Accepted
2021-12-30 16:06:01
Documents
12
Period of Report
2021-12-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d281999d8k.htm   iXBRL 8-K 24722
  Complete submission text file 0001193125-21-370585.txt   146632

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cala-20211230.xsd EX-101.SCH 2896
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20211230_lab.xml EX-101.LAB 18140
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20211230_pre.xml EX-101.PRE 11411
6 EXTRACTED XBRL INSTANCE DOCUMENT d281999d8k_htm.xml XML 3377
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36644 | Film No.: 211532909
SIC: 2834 Pharmaceutical Preparations